Adamis Pharmaceuticals Corp (ADMP) Down 2.94% in Premarket Trading

Wednesday, August 09, 2023 07:26 AM | InvestorsObserver Analysts

Mentioned in this article

Adamis Pharmaceuticals Corp (ADMP) Down 2.94% in Premarket Trading

Adamis Pharmaceuticals Corp (ADMP) has fallen Wednesday morning, with the stock declining -2.94% in pre-market trading to 1.32. ADMP's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 140 out of 146 industries, ADMP ranks higher than 0% of stocks. Adamis Pharmaceuticals Corp has fallen 36.74% over the past month, closing at $2.30 on July 12. During this period of time, the stock fell as low as $1.33 and as high as $8.28.

ADMP has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on ADMP!

See Full ADMP Report

Adamis Pharmaceuticals Corp has a Long-Term Technical rank of 20. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 80% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 134 by this metric, ADMP ranks better than 134% of stocks.

Important Dates for Investors in ADMP:

-Adamis Pharmaceuticals Corp is set to release earnings on 11/7/2023. Over the last 12 months, the company has reported EPS of $-0.05. -We do not have a set dividend date for Adamis Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Adamis Pharmaceuticals Corp (ADMP)